Skip to main content

Published

Sociodemographic inequalities in non-small cell lung cancer (NSCLC) novel treatments: a national population-based cohort study.
Rae S. Journal of Epidemiology & Community Health 2026;80(11):909-916.
[Even in the National Health Service (NHS) in England, where cancer medication access is free, inequalities in non-small cell lung cancer (NSCLC) novel therapies utilisation persisted in 2017–2021, despite more treatment options and greater clinician familiarity. There is evidence of decreasing utilisation during this study period. These findings are important to ensure equitable access to novel therapies and require further study of future trends and impact on real-world survival.]

More details
Age Groups
Adults
Older People
Conditions and Lifestyle Factors
Gender
Lung Cancer
Poverty
Race & Ethnicity
Professional Interests
Design of National Healthcare Systems
Settings
Population Health
Staff Groups
Public Health Doctor
Public Health Specialist